G5 Entertainment AB (publ) (FRA:U3I)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	73	75	113	159	345	356
Market Cap Growth	-3.10%	-33.75%	-28.93%	-53.88%	-3.26%	309.70%
Enterprise Value	47	54	94	142	332	341
Last Close Price	9.39	8.81	12.17	15.70	31.47	32.73
PE Ratio	8.47	7.21	9.85	26.46	17.89	21.41
PS Ratio	0.72	0.76	0.95	1.26	2.70	2.64
PB Ratio	1.47	1.55	2.56	3.63	7.20	8.29
P/TBV Ratio	1.48	1.56	2.57	3.63	7.20	8.29
P/FCF Ratio	3.45	3.04	5.30	5.98	10.10	13.42
P/OCF Ratio	3.43	3.03	5.21	5.81	9.83	13.31
EV/Sales Ratio	0.48	0.54	0.79	1.13	2.60	2.53
EV/EBITDA Ratio	5.63	5.53	8.70	11.54	15.08	17.09
EV/EBIT Ratio	5.93	5.72	9.21	12.14	15.44	17.66
EV/FCF Ratio	2.21	2.18	4.39	5.34	9.73	12.86
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.03	0.02
Debt / EBITDA Ratio	0.02	0.02	0.02	0.02	0.05	0.03
Debt / FCF Ratio	0.01	0.01	0.01	0.01	0.04	0.02
Asset Turnover	1.64	1.78	2.08	2.18	2.16	2.38
Quick Ratio	3.90	3.71	2.99	2.06	2.36	1.97
Current Ratio	3.90	3.71	2.99	2.12	2.40	1.98
Return on Equity (ROE)	17.09%	22.75%	26.03%	13.65%	42.89%	40.93%
Return on Assets (ROA)	8.25%	10.51%	11.15%	12.70%	22.68%	21.26%
Return on Capital (ROIC)	10.05%	12.79%	14.36%	16.36%	29.32%	28.95%
Return on Capital Employed (ROCE)	16.30%	19.30%	22.80%	26.50%	44.40%	44.70%
Earnings Yield	11.80%	13.87%	10.15%	3.78%	5.59%	4.67%
FCF Yield	28.96%	32.87%	18.88%	16.73%	9.90%	7.45%
Dividend Yield	7.77%	7.92%	5.91%	4.57%	2.16%	1.90%
Payout Ratio	66.77%	52.44%	50.56%	88.25%	27.29%	13.07%
Buyback Yield / Dilution	2.28%	2.96%	4.32%	2.27%	1.60%	3.44%
Total Shareholder Return	10.05%	10.88%	10.23%	6.84%	3.76%	5.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.